Secondary Response of Ovarian Tumors to Topotecan Treatment

Three patients presented with ovarian cancer that was initially treated with paclitaxel and platinum-based compounds. Although responses to these agents occurred, tumor progression was evident by elevated CA 125 levels after a period of 11 to 35 months. These patients were then treated with topoteca...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology 1998-06, Vol.69 (3), p.258-259
Hauptverfasser:	Dunton, Charles J., Neufeld, Julia, Carlson, John A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use Biological and medical sciences Female Female genital diseases Gynecology. Andrology. Obstetrics Humans Medical sciences Middle Aged Ovarian Neoplasms - drug therapy Retreatment Topotecan - administration & dosage Topotecan - therapeutic use Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!